180 Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.03M Sell
2,524
-44
-2% -$45K 0.3% 86
2026
Q1
$2.36M Sell
2,568
-217
-8% -$220K 0.27% 93
2025
Q4
$2.99M Sell
2,785
-25
-0.9% -$23.9K 0.34% 69
2025
Q3
$2.14M Buy
2,810
+47
+2% +$35K 0.26% 96
2025
Q2
$2.15M Buy
2,763
+129
+5% +$100K 0.3% 88
2025
Q1
$2.18M Sell
2,634
-78
-3% -$64.9K 0.35% 76
2024
Q4
$2.09M Buy
2,712
+19
+0.7% +$15.7K 0.33% 74
2024
Q3
$2.39M Sell
2,693
-136
-5% -$122K 0.38% 71
2024
Q2
$2.64M Sell
2,829
-2,098
-43% -$1.68M 0.43% 59
2024
Q1
$3.83M Buy
4,927
+2,186
+80% +$1.56M 0.69% 31
2023
Q4
$1.62M Sell
2,741
-27
-1% -$15.8K 0.32% 85
2023
Q3
$1.49M Sell
2,768
-22
-0.8% -$11.3K 0.33% 82
2023
Q2
$1.29M Sell
2,790
-51
-2% -$21.4K 0.28% 92
2023
Q1
$976K Buy
2,841
+159
+6% +$53.6K 0.23% 107
2022
Q4
$933K Buy
2,682
+105
+4% +$37.2K 0.22% 106
2022
Q3
$833K Buy
2,577
+830
+48% +$263K 0.23% 102
2022
Q2
$567K Sell
1,747
-159
-8% -$47.7K 0.14% 137
2022
Q1
$566K Sell
1,906
-158
-8% -$40.7K 0.12% 161
2021
Q4
$502K Sell
2,064
-402
-16% -$102K 0.11% 174
2021
Q3
$587K Sell
2,466
-19
-0.8% -$4.69K 0.13% 150
2021
Q2
$670K Sell
2,485
-94
-4% -$18.9K 0.15% 137
2021
Q1
$515K Sell
2,579
-259
-9% -$50.7K 0.13% 159
2020
Q4
$563K Sell
2,838
-509
-15% -$76K 0.16% 131
2020
Q3
$481K Buy
3,347
+317
+10% +$49.1K 0.18% 116
2020
Q2
$503K Buy
3,030
+154
+5% +$23.6K 0.2% 109
2020
Q1
$409K Buy
+2,876
New +$395K 0.21% 121

Other funds holding LLY

180 Wealth Advisors's LLY Position: Q2 2026 in Review

180 Wealth Advisors reduced its Eli Lilly (LLY) stake by 1.7% in Q2 2026, selling an estimated $45K and leaving 2,524 shares worth $3.03M. The position accounts for 0.3% of the portfolio, ranked #86.

180 Wealth Advisors first reported a position in LLY in Q1 2020 and has held it in 26 quarters since. The position peaked at $3.83M in Q1 2024. 1,817 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • 180 Wealth Advisors held 2,524 shares of Eli Lilly worth $3.03M as of Q2 2026.
  • 180 Wealth Advisors sold 44 Eli Lilly shares in Q2 2026, an estimated $45K.
  • Eli Lilly made up 0.3% of 180 Wealth Advisors's portfolio in Q2 2026, its #86 holding.
  • 180 Wealth Advisors first reported a position in Eli Lilly in Q1 2020 and has held it in 26 quarters since.
  • 180 Wealth Advisors's Eli Lilly position peaked at $3.83M in Q1 2024.
  • 1,817 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on 180 Wealth Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.